
MED
MEDIFAST INC
Company Overview
| Mkt Cap | $132.77M | Price | $11.15 |
| Volume | 102.59K | Change | +1.55% |
| P/E Ratio | -7.1 | Open | $10.95 |
| Revenue | $385.8M | Prev Close | $10.98 |
| Net Income | $-18.7M | 52W Range | $9.22 - $15.46 |
| Div Yield | N/A | Target | $12.00 |
| Overall | 49 | Value | 60 |
| Quality | 44 | Technical | 45 |
No chart data available
About MEDIFAST INC
Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address obesity and support a healthy life in the United States. The company offers weight loss and weight management plans; and GLP-1 support plans that provide access to GLP-1 medications where clinically appropriate under the OPTAVIA brand name. It also provides bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups, as well as provides coaching support along with community, nutrition, and healthy habits, and helps people in their weight loss journey. It markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.
Latest News
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Medpace Holdings (MEDP), Siegfried Holding AG (OtherSGFEF) and Edwards Lifesciences (EW)
Analysts Offer Insights on Healthcare Companies: Medpace Holdings (MEDP) and Acadia Healthcare (ACHC)
Medartis Investors Strongly Approve Board Proposals and Governance at 2026 AGM
Analysts Have Conflicting Sentiments on These Healthcare Companies: Elevance Health (ELV), Medpace Holdings (MEDP) and Cytokinetics (CYTK)
Medacta Group SA (MEDGF) Gets a Hold from UBS
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MED | $11.15 | +1.5% | 102.59K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |